Clinical Trials Logo
  1. Home
  2. Other
  3. NCT02732743

Food Supplement Physiomanna® Baby in Pediatric Patients

Irritable Bowel Syndrome Characterized by Constipation Clinical Trial

Official title:
An Open Label, Non-comparative Pilot Study to Assess the Efficacy and Safety of the Food Supplement Physiomanna® Baby in Pediatric Patients With a History of Functional Constipation

Clinical Trial Summary

The primary objective is to assess the efficacy and safety of the Food Supplement Physiomanna® Baby in pediatric patients with a history of functional constipation

The secondary objective of the trial is to evaluate the adherence to product's administration in the enrolled children.

Clinical Trial Description

This is an interventional, non-controlled, multicenter trial with a prospective design in one cohort of patients. This clinical investigation will be performed in 3 centers in Romania.

The tested hypothesis is that Physiomanna® Baby administration for 3 weeks, increases the SBM to be more than 2 times per week. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02732743
Study type Interventional
Source Iuppa Industriale Srl
Contact
Status Completed
Phase N/A
Start date February 2016
Completion date April 2016
View Details
See also
  Status Clinical Trial Phase
Completed NCT01622972 - Mode of Action of Moviprep Phase 4
Recruiting NCT03687814 - Low FODMAP Plus PEG 3350 for the Treatment of Patients With Irritable Bowel Syndrome-Constipation N/A
Completed NCT01722318 - The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C) Phase 2
Recruiting NCT04214470 - A Non-Interventional Pilot Study to Explore the Role of Gut Flora in IBS
Completed NCT02493452 - Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C) Phase 3
Completed NCT03573908 - A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) Phase 3
Completed NCT00948818 - Trial of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation Phase 3
Recruiting NCT03226145 - Reclassifying Constipation Using Imaging and Manometry N/A
Terminated NCT02837783 - A Study of the Effect of Linaclotide on Abdominal Girth in Participants With Irritable Bowel Syndrome With Constipation (IBS-C) Phase 4
Not yet recruiting NCT03923322 - Botanical Tincture for Symptoms of Irritable Bowel Syndrome Phase 2
Completed NCT02387359 - The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C) Phase 3